ovarian cancer and glutathione Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of Frontiers | Unveiling drug resistance
Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer Ovarian cancer in the fatty omentum: Metabolic enzyme's key role in tumor metastasis EurekAlert!
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25


